Join to View Full Profile
200 W Arbor DrSan Diego, CA 92103
Phone+1 858-657-6110
Fax+1 619-543-3183
Dr. Terkeltaub is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Scripps Clinic/Scripps Green HospitalFellowship, Allergy and Immunology, 1981 - 1984
McGill University Faculty of MedicineClass of 1976
Certifications & Licensure
CA State Medical License 1982 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- Fellow (FACR) American College of Rheumatology
Publications & Presentations
PubMed
- 1 citationsRisk of Hepatotoxicity in Patients With Gout Treated With Febuxostat or Benzbromarone: A Propensity Score-Matched Cohort Study.Wenyan Sun, Lingling Cui, Robert Terkeltaub, Ying Chen, Xinde Li
Arthritis Care & Research. 2025-09-01 - Gut bacteria degrade purines via the 2,8-dioxopurine pathway.Yuanyuan Liu, Zhiwei Zhou, J Bryce Jarman, Haoqing Chen, Michelle Miranda-Velez
Nature Microbiology. 2025-08-06 - 2 citationsPseudogout, chondrocalcinosis, CPPD et al: crystal clear… or clear as mud?-The time has come to reconsider the nomenclature of calcium pyrophosphate deposition.Silvia Sirotti, Charlotte Jauffret, Antonella Adinolfi, Edoardo Cipolletta, Daniele Cirillo
Annals of the Rheumatic Diseases. 2025-08-01
Journal Articles
- Authors’ Reply to Letter to the EditorTuhina Neogi, Robert Terkeltaub, Arthritis & Rheumatology
- Arhalofenate Acid Inhibits Monosodium Urate Crystal-Induced Inflammatory Responses Through Activation of AMP-Activated Protein Kinase (AMPK) SignalingRobert Terkeltaub, MD, BioMed Central
- Implications of the Cardiovascular Safety of Febuxostat and Allopurinol in Patients with Gout and Cardiovascular Morbidities (CARES) Trial and Associated FDA Public Sa...Robert Terkeltaub, Tuhina Neogi, Arthritis & Rheumatology
Press Mentions
IL-6 Receptor Inhibitors Show Early Promise for CPPDDecember 20th, 2024- New Look at an Ancient Disease: Study Finds Novel Treatment Targets for GoutDecember 13th, 2022
Q&A: Treatments for GoutApril 18th, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
